SHANGHAI, Dec. 18, 2024 /PRNewswire/ -- Shanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech focused on innovative IL-2-independent Tumor-Infiltrating Lymphocyte (TIL) therapies, announced the grand opening of its state-of-the-art TIL manufacturing...
Read More Details
Finally We wish PressBee provided you with enough information of ( Juncell Therapeutics Opens State-of-the-Art Facility for TIL Production )
Also on site :
- Anne Burrell's Husband Looks Somber in First Photo Since Food Network Star's Death
- Iran threatens US bases in Middle East, asserts nuclear facilities undamaged
- Trump’s Gulf Arab allies race to avoid all-out war in Iran